Concepedia

Author

Masayuki Yokode

Kyoto University

Also Known As

MASAYUKI YOKODE, Masayuki YOKODE, Masayuki Yokode, Masayuki Yokode (337155), Toshinori Murayama, Yokode Masayuki, Yokode, Masayuki, Yokode,Masayuki

207

Publications

9.6K

Citations

46

H-Index

173

Concepts

All Affiliations

Kyoto UniversityKyoto University HospitalInstitute for Atherosclerosis ResearchNational Cerebral and Cardiovascular CenterKansai Medical University
MY

About

Masayuki Yokode is an author at Kyoto University specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

39

2.5K

2

Health Sciences

11

12

1.1K

3

Engineering

3

3

190

4

Education

1

1

29

5

Natural Sciences

1

1

25

Masayuki Yokode

×

99

Publications

8.2K

Citations

42

H-Index

YearCitations

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda,

Journal of Clinical Oncology

2015

1.2K

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita, Koutaro Yokote, Hidenori Arai,

Journal of Atherosclerosis and Thrombosis

2018

791

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version

Tamio Teramoto, Junichi Sasaki, Shun Ishibashi,

Journal of Atherosclerosis and Thrombosis

2013

463

<scp>J</scp>apan as the front‐runner of super‐aged societies: Perspectives from medicine and medical care in <scp>J</scp>apan

Hidenori Arai, Yasuyoshi Ouchi, Kenji Toba,

Geriatrics and gerontology international/Geriatrics & gerontology international

2015

391

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( <i>Srebp2</i> ) regulates HDL in vivo

Takahiro Horie, Koh Ono, Masahito Horiguchi,

Proceedings of the National Academy of Sciences

2010

373

Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice

Takuya Kobayashi, Yoshio Tahara, Mayumi Matsumoto,

Journal of Clinical Investigation

2004

359

A High Glycolytic Flux Supports the Proliferative Potential of Murine Embryonic Stem Cells

Hiroshi Kondoh, Matilde E. Lleonart, Yasuhiro Nakashima,

Antioxidants and Redox Signaling

2007

325

Diagnostic Criteria for Dyslipidemia - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese

Tamio Teramoto, Junichi Sasaki, Hirotsugu Ueshima,

Journal of Atherosclerosis and Thrombosis

2007

225

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice

Takahiro Horie, Tomohiro Nishino, Osamu Baba,

Nature Communications

2013

225

MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE <sup>−/−</sup> Mice

Takahiro Horie, Osamu Baba, Yasuhide Kuwabara,

Journal of the American Heart Association

2012

218

Page 1